tirzepatide indication Day 4: Zepbound (Tirzepatide – weight loss indication) FDA Approved: November 2023 for weight management Weight Loss: Up to 22.5% in clinical trials Similar to Mounjaro, but marketed specifically for weight management Lilly's Mounjaro tops other GLP-1s

RELATED: How to save on Mounjaro Is compounded tirzepatide safe

Track your progress Whether its journaling or using an app, keeping tabs on your weight, appetite, and mood can help keep you motivated

Individual timelines vary based on starting dose, prior medication history, and genetic factors that influence peptide pathway responsiveness

These baseline values allow your provider to detect changes early and distinguish medication-related effects from pre-existing conditions

Our lawyers understand the specific regulatory environment that wellness businesses operate in, and we provide practical, plain-language advice that helps you run your business confidently